miR-145在消化系统肿瘤中的研究进展
Research Progress on miR-145 in Digestive System Tumors
DOI: 10.12677/acm.2025.15113087, PDF,   
作者: 李江华*:吉首大学医学院,湖南 吉首;陈 迅#:中南大学湘雅医学院附属株洲医院肝胆胰脾外二科,湖南 株洲
关键词: miR-145消化系统肿瘤研究进展miR-145 Digestive System Tumors Research Progress
摘要: MicroRNA (miRNA)是一类高度保守、化学稳定、小的非编码内源性分子。自1993年发现第一个miRNAs以来,其功能得到了更深入的研究,HO等研究了其多步骤生物发生过程始于细胞核、结束于细胞质以及细胞外输出的过程,被认为是诊断和疾病预后的有前途的生物标志物,且可以利用其进行无创诊断和预后。由于miRNAs在转录后水平上具有调节靶基因的表达功能,可控制至少60%的蛋白编码基因的表达。单个miRNA可以调控多种蛋白表达,而一种蛋白表达也能受到多个miRNA的调控,从而形成了一个完整且复杂的调控网络系统。miRNAs在人类很多生理过程中发挥了重要的调节作用,包括细胞增殖与分化、新陈代谢、凋亡等;而miRNA异常表达与多种人类疾病相关,尤其是在肿瘤疾病方面。作为microRNA家族的一员,miR-145是一种常见的肿瘤相关microRNA。近年来,许多研究发现miR-145在多种人类消化系统肿瘤中表达失调,癌组织中miR-145的异常表达证实了其在癌症发生中的重要作用。miR-145可作为非侵入性生物标志物,有望在早期消化系统癌症检测中发挥作用。现就miR-145在消化系统肿瘤中的研究进展进行综述。
Abstract: MicroRNAs (miRNAs) are a class of highly conserved, chemically stable, small non-coding endogenous molecules. Since the discovery of the first miRNA in 1993, their functions have been extensively investigated. HO et al. elucidated the multi-step biogenesis process of miRNAs, which begins in the nucleus, concludes in the cytoplasm, and involves extracellular export. miRNAs are recognized as promising biomarkers for diagnosis and disease prognosis, enabling non-invasive diagnostic and prognostic applications. By regulating target gene expression at the post-transcriptional level, miRNAs control the expression of at least 60% of protein-coding genes. A single miRNA can modulate the expression of multiple proteins, while the expression of a single protein can be regulated by multiple miRNAs, forming a comprehensive and complex regulatory network. miRNAs play critical roles in various human physiological processes, including cell proliferation, differentiation, metabolism, and apoptosis. Abnormal miRNA expression is associated with numerous human diseases, particularly tumors. As a member of the miRNA family, miR-145 is a commonly studied tumor-associated miRNA. Recent studies have revealed dysregulated expression of miR-145 in various human digestive system tumors. Abnormal expression of miR-145 in cancerous tissues confirms its significant role in tumorigenesis. miR-145 may serve as a non-invasive biomarker with potential applications in the early detection of digestive system cancers. This review summarizes the research progress on miR-145 in digestive system tumors.
文章引用:李江华, 陈迅. miR-145在消化系统肿瘤中的研究进展[J]. 临床医学进展, 2025, 15(11): 213-220. https://doi.org/10.12677/acm.2025.15113087

参考文献

[1] Karimi, L., Mansoori, B., Shanebandi, D., Mohammadi, A., Aghapour, M. and Baradaran, B. (2017) Function of MicroRNA-143 in Different Signal Pathways in Cancer: New Insights into Cancer Therapy. Biomedicine & Pharmacotherapy, 91, 121-131. [Google Scholar] [CrossRef] [PubMed]
[2] Gu, X., Zhang, J., Ran, Y., Pan, H., Jia, J., Zhao, Y., et al. (2021) Circular RNA Hsa_circ_101555 Promotes Hepatocellular Carcinoma Cell Proliferation and Migration by Sponging miR-145-5p and Regulating CDCA3 Expression. Cell Death & Disease, 12, Article No. 356. [Google Scholar] [CrossRef] [PubMed]
[3] Tao, H., Song, S., Fan, Z., Li, W., Jin, X., Jiang, W., et al. (2024) PKCiota Inhibits the Ferroptosis of Esophageal Cancer Cells via Suppressing USP14-Mediated Autophagic Degradation of GPX4. Antioxidants, 13, Article 114. [Google Scholar] [CrossRef] [PubMed]
[4] Su, X., Feng, X., Gao, C., et al. (2020) ROR Promotes the Proliferation and Migration of Esophageal Cancer through Regulating miR-145/LMNB2 Signal Axis. American Journal of Translational Research, 12, 7223-7235.
[5] Zhang, Y., Zhang, L., Wang, R., Wang, B., Hua, P. and Li, J. (2019) LncRNA Erbb4-IR Promotes Esophageal Squamous Cell Carcinoma (ESCC) by Downregulating miR-145. Journal of Cellular Biochemistry, 120, 17566-17572. [Google Scholar] [CrossRef] [PubMed]
[6] Jin, W., Luo, W., Fang, W., Wang, Y., Wang, L., Shen, Q., et al. (2019) miR-145 Expression Level in Tissue Predicts Prognosis of Patients with Esophageal Squamous Cell Carcinoma. PathologyResearch and Practice, 215, Article 152401. [Google Scholar] [CrossRef] [PubMed]
[7] Zhou, T., Chen, S. and Mao, X. (2019) miR-145-5p Affects the Differentiation of Gastric Cancer by Targeting KLF5 Directly. Journal of Cellular Physiology, 234, 7634-7644. [Google Scholar] [CrossRef] [PubMed]
[8] Wei, C., Jiang, P., Li, G., et al. (2022) 5,7,2,5-Tetrahydroxy-8,6-Dimethoxyflavone Up-Regulates miR-145 Expression and Inhibits Proliferation of Gastric Cancer Cells. Archives of Medical Science, 18, 753-760. [Google Scholar] [CrossRef] [PubMed]
[9] 赵雪峰, 谭明, 赵一杰, 等. 微小RNA-145表达对胃癌不同分子分型患者的新辅助化疗效果评价及临床意义[J]. 河北医药, 2022, 44(13): 1962-1965.
[10] Wang, J., Sun, Z., Yan, S. and Gao, F. (2019) Effect of miR‑145 on Gastric Cancer Cells. Molecular Medicine Reports, 19, 3403-3410. [Google Scholar] [CrossRef] [PubMed]
[11] Lei, C., Du, F., Sun, L., Li, T., Li, T., Min, Y., et al. (2017) miR-143 and miR-145 Inhibit Gastric Cancer Cell Migration and Metastasis by Suppressing MYO6. Cell Death & Disease, 8, e3101-e3101. [Google Scholar] [CrossRef] [PubMed]
[12] 景晓华, 杨学军, 雒夏. microrna-145过表达抑制人肝癌细胞株HepG2细胞增殖并诱导其凋亡的研究[J]. 宁夏医学杂志, 2019, 41(4): 308-312+288.
[13] 袁俊建, 孔德帅, 陈雄飞, 等. miR-143、miR-145联合血清AFP检测对原发性肝癌的临床诊断价值[J]. 解放军医药杂志, 2019, 31(7): 29-32.
[14] 王霖沛, 马筱秋, 黄卫锋, 王伟, 余外市, 骆锦彬. 微小RNA-145对CD44表达以及肝癌细胞影响[J]. 中华肝胆外科杂志, 2019, 25(3): 179-183.
[15] Lu, F., Gao, J., Luo, Y., Jin, W., Wang, H., Li, C., et al. (2023) Circcpsf6 Promotes Hepatocellular Carcinoma Cancer Progression by Regulating MAP4K4 through Sponging miR-145-5p. Molecular and Cellular Probes, 71, Article 101920. [Google Scholar] [CrossRef] [PubMed]
[16] Li, P., Fan, H. and He, Q. (2018) Investigation of the Clinical Significance and Prognostic Value of MicroRNA-145 in Human Hepatocellular Carcinoma. Medicine, 97, e13715. [Google Scholar] [CrossRef] [PubMed]
[17] 丁乙轩, 曹锋, 王业成, 郭玉霖, 卢炯地, 梅文通, 李非. 间充质干细胞来源的外泌体转运微小RNA-145-5p对胰腺癌细胞的影响[J]. 中华实验外科杂志, 2019, 36(6): 1052-1054.
[18] 依力哈木·买买提, 钟锴, 艾合散·卡马力, 等. 环状RNA circ_0020123靶向调控微小RNA-145影响胰腺癌细胞SW-1990增殖、侵袭与转移实验研究[J]. 陕西医学杂志, 2023, 52(9): 1140-1144.
[19] 胡松, 周文杰, 徐天天, 等. miR-145-5p靶向PLCE1对胰腺癌细胞增殖、分化和凋亡的机制研究[J]. 现代消化及介入诊疗, 2019, 24(10): 1123-1128+1132.
[20] 邓大炜, 吴斌, 严舒, 等. miR-145对胰腺癌细胞系PANC-1上皮间质转化及肿瘤干细胞增殖的影响[J]. 基础医学与临床, 2018, 38(8): 1135-1140.
[21] Setua, S., Khan, S., Doxtater, K., et al. (2017) miR-145: Revival of a Dragon in Pancreatic Cancer. Journal of Natural Science, 3, e332.
[22] Setua, S., Khan, S., Yallapu, M.M., Behrman, S.W., Sikander, M., Khan, S.S., et al. (2017) Restitution of Tumor Suppressor MicroRNA-145 Using Magnetic Nanoformulation for Pancreatic Cancer Therapy. Journal of Gastrointestinal Surgery, 21, 94-105. [Google Scholar] [CrossRef] [PubMed]
[23] Li, C., Yan, G., Yin, L., Liu, T., Li, C. and Wang, L. (2019) Prognostic Roles of MicroRNA 143 and MicroRNA 145 in Colorectal Cancer: A Meta-Analysis. The International Journal of Biological Markers, 34, 6-14. [Google Scholar] [CrossRef] [PubMed]
[24] Chen, Q., Zhou, L., Ye, X., Tao, M. and Wu, J. (2020) miR-145-5p Suppresses Proliferation, Metastasis and EMT of Colorectal Cancer by Targeting CDCA3. PathologyResearch and Practice, 216, Article 152872. [Google Scholar] [CrossRef] [PubMed]
[25] 熊新魁, 杜也牧, 刘雨亭, 等. miR-145抑制人肝内胆管细胞癌细胞增殖[J]. 基础医学与临床, 2019, 39(1): 63-69.
[26] Sachdeva, M., Zhu, S., Wu, F., Wu, H., Walia, V., Kumar, S., et al. (2009) P53 Represses c-MYC through Induction of the Tumor Suppressor miR-145. Proceedings of the National Academy of Sciences, 106, 3207-3212. [Google Scholar] [CrossRef] [PubMed]